Literature DB >> 21788950

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

D Martín-Pérez, P Vargiu, S Montes-Moreno, E A León, S M Rodríguez-Pinilla, L D Lisio, N Martínez, R Rodríguez, M Mollejo, J Castellvi, D G Pisano, M Sánchez-Beato, M A Piris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21788950     DOI： 10.1038/leu.2011.189

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  23 in total

Review 1.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Epstein-Barr virus (EBV) provides survival factors to EBV+ diffuse large B-cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+  DLBCL.

Authors:  Liang Wu; Barbro Ehlin-Henriksson; Xiaoying Zhou; Hong Zhu; Ingemar Ernberg; Lorand L Kis; George Klein
Journal:  Immunology       Date:  2017-08-11       Impact factor: 7.397

Review 3.  NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.

Authors:  Li Yu; Ling Li; L Jeffrey Medeiros; Ken H Young
Journal:  Blood Rev       Date:  2016-10-13       Impact factor: 8.250

4.  EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment.

Authors:  Alina Nicolae; Stefania Pittaluga; Shahed Abdullah; Seth M Steinberg; Thu Anh Pham; Theresa Davies-Hill; Liqiang Xi; Mark Raffeld; Elaine S Jaffe
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

5.  MicroRNAs in diffuse large B-cell lymphoma.

Authors:  Huiyun Ni; Rong Tong; Linqing Zou; Guoqi Song; William C Cho
Journal:  Oncol Lett       Date:  2015-12-28       Impact factor: 2.967

Review 6.  Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL).

Authors:  Krystyna Mazan-Mamczarz; Ronald B Gartenhaus
Journal:  Leuk Res       Date:  2013-09-07       Impact factor: 3.156

Review 7.  A review on EBV encoded and EBV-induced host microRNAs expression profile in different lymphoma types.

Authors:  Saber Soltani; Armin Zakeri; Alireza Tabibzadeh; Amir Mohammad Zakeri; Milad Zandi; Saba Siavoshi; Saba Seifpour; Abbas Farahani
Journal:  Mol Biol Rep       Date:  2021-02-01       Impact factor: 2.316

Review 8.  Mutual interaction between BCL6 and miRNAs contributing to the pathogenesis of various cancers.

Authors:  Z Wei; W Gao; Y Wu; B Ni; Y Tian
Journal:  Clin Transl Oncol       Date:  2015-06-25       Impact factor: 3.405

9.  Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.

Authors:  Chi Young Ok; Ling Li; Zijun Y Xu-Monette; Carlo Visco; Alexander Tzankov; Ganiraju C Manyam; Santiago Montes-Moreno; Karen Dybkaer; Karen Dybaer; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Jiayu Chen; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Weiyun Ai; Maurilio Ponzoni; Andrés J M Ferreri; John P Farnen; Michael B Møller; Carlo E Bueso-Ramos; Roberto N Miranda; Jane N Winter; Miguel A Piris; L Jeffrey Medeiros; Ken H Young
Journal:  Clin Cancer Res       Date:  2014-02-28       Impact factor: 12.531

10.  Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era.

Authors:  Lindsay M Morton; Clara J Kim; Lawrence M Weiss; Kishor Bhatia; Myles Cockburn; Debra Hawes; Sophia S Wang; Cindy Chang; Sean F Altekruse; Eric A Engels; Wendy Cozen
Journal:  Leuk Lymphoma       Date:  2013-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.